# Metabolomics Profiling of Coronary Heart Disease

> **NCT05138731** · — · UNKNOWN · sponsor: **General Hospital of Ningxia Medical University** · enrollment: 821 (estimated)

## Conditions studied

- Biomarkers

## Interventions

- **OTHER:** treatments according guidelines

## Key facts

- **NCT ID:** NCT05138731
- **Lead sponsor:** General Hospital of Ningxia Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-05-30
- **Target enrollment:** 821 (ESTIMATED)
- **Last updated:** 2022-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05138731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05138731, "Metabolomics Profiling of Coronary Heart Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05138731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*